By Professor Cynthia Shannon Weickert

Journal articles

Laskaris L; Zalesky A; Weickert CS; Di Biase MA; Chana G; Baune BT; Bousman C; Nelson B; McGorry P; Everall I; Pantelis C; Cropley V, 2019, 'Investigation of peripheral complement factors across stages of psychosis', Schizophrenia Research, 204, pp. 30 - 37, http://dx.doi.org/10.1016/j.schres.2018.11.035

Weissleder C; Barry G; Fung SJ; Wong MW; Double KL; Webster MJ; Weickert CS, 2019, 'Reduction in IGF1 mRNA in the human subependymal zone during aging', Aging and Disease, 10, pp. 197 - 204, http://dx.doi.org/10.14336/AD.2018.0317

Wannan CMJ; Cropley VL; Chakravarty MM; Bousman C; Ganella EP; Bruggemann JM; Weickert TW; Weickert CS; Everall I; McGorry P; Velakoulis D; Wood SJ; Bartholomeusz CF; Pantelis C; Zalesky A, 2019, 'Evidence for network-based cortical thickness reductions in schizophrenia', American Journal of Psychiatry, 176, pp. 552 - 563, http://dx.doi.org/10.1176/appi.ajp.2019.18040380

Murphy CE; Walker AK; Shannon Weickert C, 2019, 'Where There's Smoke, There's Fire—But Who Is Lighting the Match? Bolstering Transcriptional Evidence for the Role of Nuclear Factor-κB in Neuroimmune Activation in Schizophrenia', Biological Psychiatry, 85, pp. 5 - 7, http://dx.doi.org/10.1016/j.biopsych.2018.10.019

Owens SJ; Weickert TW; Purves-Tyson TD; Ji E; White C; Galletly C; Liu D; O'Donnell M; Shannon Weickert C, 2019, 'Sex-Specific Associations of Androgen Receptor CAG Trinucleotide Repeat Length and of Raloxifene Treatment with Testosterone Levels and Perceived Stress in Schizophrenia.', Mol Neuropsychiatry, 5, pp. 28 - 41, http://dx.doi.org/10.1159/000495062

Fullerton JM; Klauser P; Lenroot RK; Shaw AD; Overs B; Heath A; Cairns MJ; Atkins J; Scott R; Schofield PR; Weickert CS; Pantelis C; Fornito A; Whitford TJ; Weickert TW; Zalesky A, 2018, 'Differential effect of disease-associated ST8SIA2 haplotype on cerebral white matter diffusion properties in schizophrenia and healthy controls', Translational Psychiatry, 8, pp. 21, http://dx.doi.org/10.1038/s41398-017-0052-z

Maier RM; Zhu Z; Lee SH; Trzaskowski M; Ruderfer DM; Stahl EA; Ripke S; Wray NR; Yang J; Visscher PM; Robinson MR; Forstner AJ; Mcquillin A; Trubetskoy V; Wang W; Wang Y; Coleman JRI; Gaspar HA; De Leeuw CA; Whitehead Pavlides JM; Olde Loohuis LM; Pers TH; Lee PH; Charney AW; Dobbyn AL; Huckins L; Boocock J; Giambartolomei C; Roussos P; Mullins N; Awasthi S; Agerbo E; Als TD; Pedersen CB; Grove J; Kupka R; Regeer EJ; Anjorin A; Casas M; Mahon PB; Allardyce J; Escott-Price V; Forty L; Fraser C; Kogevinas M; Frank J; Streit F; Strohmaier J; Treutlein J; Witt SH; Kennedy JL; Strauss JS; Garnham J; O'donovan C; Slaney C; Steinberg S; Thorgeirsson TE; Hautzinger M; Steffens M; Perlis RH; Sánchez-Mora C; Hipolito M; Lawson WB; Nwulia EA; Levy SE; Foroud TM; Jamain S; Young AH; Mckay JD; Albani D; Zandi P; Potash JB; Zhang P; Raymond Depaulo J; Bergen SE; Juréus A; Karlsson R; Kandaswamy R; Mcguffin P; Rivera M; Lissowska J; Cruceanu C; Lucae S; Cervantes P; Budde M; Gade K; Heilbronner U; Pedersen MG; Morris DW; Weickert CS; Weickert TW; Macintyre DJ; Lawrence J; Elvsåshagen T; Smeland OB; Djurovic S; Xi S; Green EK; Czerski PM; Hauser J, 2018, 'Improving genetic prediction by leveraging genetic correlations among human diseases and traits', Nature Communications, 9, http://dx.doi.org/10.1038/s41467-017-02769-6

Breen MS; Ozcan S; Ramsey JM; Wang Z; Ma’ayan A; Rustogi N; Gottschalk MG; Webster MJ; Weickert CS; Buxbaum JD; Bahn S, 2018, 'Temporal proteomic profiling of postnatal human cortical development', Translational Psychiatry, 8, pp. 267, http://dx.doi.org/10.1038/s41398-018-0306-4

Hoffmann C; Van Rheenen TE; Mancuso SG; Zalesky A; Bruggemann J; Lenroot RK; Sundram S; Weickert CS; Weickert TW; Pantelis C; Cropley V; Bousman CA, 2018, 'Exploring the moderating effects of dopaminergic polymorphisms and childhood adversity on brain morphology in schizophrenia-spectrum disorders', Psychiatry Research - Neuroimaging, 281, pp. 61 - 68, http://dx.doi.org/10.1016/j.pscychresns.2018.09.002

van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R; Okada N; Yamamori H; Bustillo JR; Clark VP; Agartz I; Mueller BA; Cahn W; de Zwarte SMC; Hulshoff Pol HE; Kahn RS; Ophoff RA; van Haren NEM; Andreassen OA; Dale AM; Doan NT; Gurholt TP; Hartberg CB; Haukvik UK; Jørgensen KN; Lagerberg TV; Melle I; Westlye LT; Gruber O; Kraemer B; Richter A; Zilles D; Calhoun VD; Crespo-Facorro B; Roiz-Santiañez R; Tordesillas-Gutiérrez D; Loughland C; Carr VJ; Catts S; Cropley VL; Fullerton JM; Green MJ; Henskens FA; Jablensky A; Lenroot RK; Mowry BJ; Michie PT; Pantelis C; Quidé Y; Schall U; Scott RJ; Cairns MJ; Seal M; Tooney PA; Rasser PE; Cooper G; Shannon Weickert C; Weickert TW; Morris DW; Hong E; Kochunov P; Beard LM; Gur RE; Gur RC; Satterthwaite TD; Wolf DH; Belger A; Brown GG; Ford JM; Macciardi F; Mathalon DH; O'Leary DS; Potkin SG; Preda A; Voyvodic J; Lim KO; McEwen S; Yang F; Tan Y; Tan S; Wang Z; Fan F; Chen J; Xiang H; Tang S; Guo H; Wan P; Wei D; Bockholt HJ; Ehrlich S; Wolthusen RPF; King MD; Shoemaker JM; Sponheim SR; De Haan L; Koenders L; Quide Y, 2018, 'Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium', Biological Psychiatry, 84, pp. 644 - 654, http://dx.doi.org/10.1016/j.biopsych.2018.04.023

Martin DM; McClintock SM; Aaronson ST; Alonzo A; Husain MM; Lisanby SH; McDonald WM; Mohan A; Nikolin S; O'Reardon J; Weickert CS; Loo CK, 2018, 'Pre-treatment attentional processing speed and antidepressant response to transcranial direct current stimulation: Results from an international randomized controlled trial', Brain Stimulation, 11, pp. 1282 - 1290, http://dx.doi.org/10.1016/j.brs.2018.08.011

Olaya JC; Heusner CL; Matsumoto M; Shannon Weickert C; Karl T, 2018, 'Schizophrenia-relevant behaviours of female mice overexpressing neuregulin 1 type III', Behavioural Brain Research, 353, pp. 227 - 235, http://dx.doi.org/10.1016/j.bbr.2018.03.026

Jacomb I; Stanton C; Vasudevan R; Powell H; O'Donnell M; Lenroot R; Bruggemann J; Balzan R; Galletly C; Liu D; Weickert CS; Weickert TW, 2018, 'C-Reactive protein: Higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls', Frontiers in Immunology, 9, pp. 2230, http://dx.doi.org/10.3389/fimmu.2018.02230

Mohan A; Thalamuthu A; Mather KA; Zhang Y; Catts VS; Weickert CS; Sachdev PS, 2018, 'Differential expression of synaptic and interneuron genes in the aging human prefrontal cortex', Neurobiology of Aging, 70, pp. 194 - 202, http://dx.doi.org/10.1016/j.neurobiolaging.2018.06.011

Zhang Y; Catts VS; Shannon Weickert C, 2018, 'Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia', Australian and New Zealand Journal of Psychiatry, 52, pp. 690 - 698, http://dx.doi.org/10.1177/0004867417728805

Lloyd D; Talmage D; Shannon Weickert C; Karl T, 2018, 'Reduced type III neuregulin 1 expression does not modulate the behavioural sensitivity of mice to acute Δ ⁹ -tetrahydrocannabinol (D ⁹ -THC)', Pharmacology Biochemistry and Behavior, 170, pp. 64 - 70, http://dx.doi.org/10.1016/j.pbb.2018.05.003

Ruderfer DM; Ripke S; McQuillin A; Boocock J; Stahl EA; Pavlides JMW; Mullins N; Charney AW; Ori APS; Loohuis LMO; Domenici E; Di Florio A; Papiol S; Kalman JL; Trubetskoy V; Adolfsson R; Agartz I; Agerbo E; Akil H; Albani D; Albus M; Alda M; Alexander M; Alliey-Rodriguez N; Als TD; Amin F; Anjorin A; Arranz MJ; Awasthi S; Bacanu SA; Badner JA; Baekvad-Hansen M; Bakker S; Band G; Barchas JD; Barroso I; Bass N; Bauer M; Baune BT; Begemann M; Bellenguez C; Belliveau RA; Bellivier F; Bender S; Bene J; Bergen SE; Berrettini WH; Bevilacqua E; Biernacka JM; Bigdeli TB; Black DW; Blackburn H; Blackwell JM; Blackwood DHR; Pedersen CB; Boehnke M; Boks M; Borglum AD; Bramon E; Breen G; Brown MA; Bruggeman R; Buccola NG; Buckner RL; Budde M; Bulik-Sullivan B; Bumpstead SJ; Bunney W; Burmeister M; Buxbaum JD; Bybjerg-Grauholm J; Byerley W; Cahn W; Cai G; Cairns MJ; Campion D; Cantor RM; Carr VJ; Carrera N; Casas JP; Casas M; Catts SV; Cervantes P; Chambert KD; Chan RCK; Chen EYH; Chen RYL; Cheng W; Cheung EFC; Chong SA; Clarke TK; Cloninger CR; Cohen D; Cohen N; Coleman JRI; Collier DA; Cormican P; Coryell W; Craddock N; Craig DW; Shannon Weickert C; Giannoulatou E; Schofield P; Weickert T; Mitchell P; Green M; Fullerton J; Hammond N, 2018, 'Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes', Cell, 173, pp. 1705 - 1715.e16, http://dx.doi.org/10.1016/j.cell.2018.05.046

Kelly S; Jahanshad N; Zalesky A; Kochunov P; Agartz I; Alloza C; Andreassen OA; Arango C; Banaj N; Bouix S; Bousman CA; Brouwer RM; Bruggemann J; Bustillo J; Cahn W; Calhoun V; Cannon D; Carr V; Catts S; Chen J; Chen JX; Chen X; Chiapponi C; Cho KK; Ciullo V; Corvin AS; Crespo-Facorro B; Cropley V; De Rossi P; Diaz-Caneja CM; Dickie EW; Ehrlich S; Fan FM; Faskowitz J; Fatouros-Bergman H; Flyckt L; Ford JM; Fouche JP; Fukunaga M; Gill M; Glahn DC; Gollub R; Goudzwaard ED; Guo H; Gur RE; Gur RC; Gurholt TP; Hashimoto R; Hatton SN; Henskens FA; Hibar DP; Hickie IB; Hong LE; Horacek J; Howells FM; Hulshoff Pol HE; Hyde CL; Isaev D; Jablensky A; Jansen PR; Janssen J; Jönsson EG; Jung LA; Kahn RS; Kikinis Z; Liu K; Klauser P; Knöchel C; Kubicki M; Lagopoulos J; Langen C; Lawrie S; Lenroot RK; Lim KO; Lopez-Jaramillo C; Lyall A; Magnotta V; Mandl RCW; Mathalon DH; McCarley RW; McCarthy-Jones S; McDonald C; McEwen S; McIntosh A; Melicher T; Mesholam-Gately RI; Michie PT; Mowry B; Mueller BA; Newell DT; O'Donnell P; Oertel-Knöchel V; Oestreich L; Paciga SA; Pantelis C; Pasternak O; Pearlson G; Pellicano GR; Pereira A; Pineda Zapata J; Shannon Weickert C; Whitford T; Weickert T, 2018, 'Widespread white matter microstructural differences in schizophrenia across 4322 individuals: Results from the ENIGMA Schizophrenia DTI Working Group', Molecular Psychiatry, 23, pp. 1261 - 1269, http://dx.doi.org/10.1038/mp.2017.170

Van Rheenen TE; Cropley V; Zalesky A; Bousman C; Wells R; Bruggemann J; Sundram S; Weinberg D; Lenroot RK; Pereira A; Shannon Weickert C; Weickert TW; Pantelis C, 2018, 'Widespread Volumetric Reductions in Schizophrenia and Schizoaffective Patients Displaying Compromised Cognitive Abilities', Schizophrenia Bulletin, 44, pp. 560 - 574, http://dx.doi.org/10.1093/schbul/sbx109

Purves-Tyson T; Rothmond D; Weickert CS, 2018, '40.1 INFLAMMATORY CYTOKINES ARE ELEVATED IN THE MIDBRAIN IN SCHIZOPHRENIA', Schizophrenia Bulletin, 44, pp. S64 - S64, http://dx.doi.org/10.1093/schbul/sby014.164

Bousman CA; Cropley V; Klauser P; Hess JL; Pereira A; Idrizi R; Bruggemann J; Mostaid MS; Lenroot R; Weickert TW; Glatt SJ; Everall IP; Sundram S; Zalesky A; Weickert CS; Pantelis C, 2018, 'Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia', Psychological Medicine, 48, pp. 801 - 809, http://dx.doi.org/10.1017/S0033291717002173

Weickert T; Cai H; O’Donnell M; Balzan R; Wells R; Liu D; Galletly C; Weickert CS, 2018, 'O1.5. ICAM-1 IS INCREASED IN BRAIN AND PERIPHERAL LEVELS OF SOLUBLE ICAM-1 IS RELATED TO COGNITIVE DEFICITS IN SCHIZOPHRENIA', Schizophrenia Bulletin, 44, pp. S73 - S74, http://dx.doi.org/10.1093/schbul/sby015.187

Chesworth R; Long LE; Weickert CS; Karl T, 2018, 'The endocannabinoid system across postnatal development in transmembrane domain Neuregulin 1 mutant mice', Frontiers in Psychiatry, 9, pp. 11, http://dx.doi.org/10.3389/fpsyt.2018.00011

Owens SJ; Murphy CE; Purves-Tyson TD; Weickert TW; Shannon Weickert C, 2018, 'Considering the role of adolescent sex steroids in schizophrenia', Journal of Neuroendocrinology, 30, http://dx.doi.org/10.1111/jne.12538

Hagihara H; Catts VS; Katayama Y; Shoji H; Takagi T; Huang FL; Nakao A; Mori Y; Huang KP; Ishii S; Graef IA; Nakayama KI; Shannon Weickert C; Miyakawa T, 2018, 'Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders', Neuropsychopharmacology, 43, pp. 459 - 468, http://dx.doi.org/10.1038/npp.2017.167

Karis K; Eskla KL; Kaare M; Täht K; Tuusov J; Visnapuu T; Innos J; Jayaram M; Timmusk T; Weickert CS; Väli M; Vasar E; Philips MA, 2018, 'Altered expression profile of igLON family of neural cell adhesion molecules in the dorsolateral prefrontal cortex of schizophrenic patients', Frontiers in Molecular Neuroscience, 11, pp. 8, http://dx.doi.org/10.3389/fnmol.2018.00008

Tsai SY; Catts VS; Fullerton JM; Corley SM; Fillman SG; Shannon Weickert C, 2018, 'Nuclear Receptors and Neuroinflammation in Schizophrenia', Mol Neuropsychiatry, 3, pp. 181 - 191, http://dx.doi.org/10.1159/000485565

Loo CK; Husain MM; McDonald WM; Aaronson S; O'Reardon JP; Alonzo A; Weickert CS; Martin DM; McClintock SM; Mohan A; Lisanby SH; Krystal AD; Peterchev AV; Davis W; Sklar J; Colagiuri B; Galvez V; Loo C, 2018, 'International randomized-controlled trial of transcranial Direct Current Stimulation in depression', Brain Stimulation, 11, pp. 125 - 133, http://dx.doi.org/10.1016/j.brs.2017.10.011

Mostaid MS; Lee TT; Chana G; Sundram S; Shannon Weickert C; Pantelis C; Everall I; Bousman C, 2017, 'Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients', Translational Psychiatry, 7, pp. 1280, http://dx.doi.org/10.1038/s41398-017-0041-2

Mostaid MS; Lee TT; Chana G; Sundram S; Weickert CS; Pantelis C; Everall I; Bousman C, 2017, 'Peripheral transcription of NRG-ErbB pathway genes are upregulated in treatment-resistant schizophrenia', Frontiers in Psychiatry, 8, pp. 225, http://dx.doi.org/10.3389/fpsyt.2017.00225

Weickert TW; Weickert CS, 2017, 'Raloxifene improves cognition in schizophrenia: Spurious result or valid effect?', Frontiers in Psychiatry, 8, pp. 202, http://dx.doi.org/10.3389/fpsyt.2017.00202

Mathews KJ; Allen KM; Boerrigter D; Ball H; Shannon Weickert C; Double KL, 2017, 'Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers', Aging Cell, 16, pp. 1195 - 1199, http://dx.doi.org/10.1111/acel.12641

Boerrigter D; Weickert TW; Lenroot R; O'Donnell M; Galletly C; Liu D; Burgess M; Cadiz R; Jacomb I; Catts VS; Fillman SG; Weickert CS, 2017, 'Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder', Journal of Neuroinflammation, 14, pp. 188, http://dx.doi.org/10.1186/s12974-017-0962-y

Olaya JC; Heusner CL; Matsumoto M; Sinclair D; Kondo MA; Karl T; Shannon Weickert C, 2017, 'Overexpression of Neuregulin 1 Type III Confers Hippocampal mRNA Alterations and Schizophrenia-Like Behaviors in Mice.', Schizophr Bull, 44, pp. 865 - 875, http://dx.doi.org/10.1093/schbul/sbx122

Rahman T; Zavitsanou K; Purves-Tyson T; Harms LR; Meehan C; Schall U; Todd J; Hodgson DM; Michie PT; Weickert CS, 2017, 'Effects of immune activation during early or late gestation on N-Methyl-D-Aspartate receptor measures in adult rat offspring', Frontiers in Psychiatry, 8, pp. 77, http://dx.doi.org/10.3389/fpsyt.2017.00077

Weissleder C; Kondo MA; Yang C; Fung SJ; Rothmond DA; Wong MW; Halliday GM; Herman MM; Kleinman JE; Webster MJ; Shannon Weickert C, 2017, 'Early-life decline in neurogenesis markers and age-related changes of TrkB splice variant expression in the human subependymal zone', European Journal of Neuroscience, 46, pp. 1768 - 1778, http://dx.doi.org/10.1111/ejn.13623

Meehan C; Harms L; Frost JD; Barreto R; Todd J; Schall U; Shannon Weickert C; Zavitsanou K; Michie PT; Hodgson DM, 2017, 'Effects of immune activation during early or late gestation on schizophrenia-related behaviour in adult rat offspring', Brain, Behavior, and Immunity, 63, pp. 8 - 20, http://dx.doi.org/10.1016/j.bbi.2016.07.144

Weickert T; Kindler J; Zavitsanou K; Lim C; Guillemin G; Galletly C; Liu D; Balzan R; Boerrigter D; Bruggemann J; O’Donnell M; Lenroot R; Weickert CS, 2017, '128. Dysregulation of Kynurenine Metabolism is Related to Proinflammatory Cytokines, Prefrontal Cortex Volume, and Attention in Schizophrenia', Schizophrenia Bulletin, 43, pp. S70 - S70, http://dx.doi.org/10.1093/schbul/sbx021.186

Cropley VL; Klauser P; Lenroot RK; Bruggemann J; Sundram S; Bousman C; Pereira A; Di Biase MA; Weickert TW; Weickert CS; Pantelis C; Zalesky A, 2017, 'Accelerated gray and white matter deterioration with age in schizophrenia', American Journal of Psychiatry, 174, pp. 286 - 295, http://dx.doi.org/10.1176/appi.ajp.2016.16050610

Burgess M; Boerrigter D; Weickert T; Lenroot R; O’Donnell M; Galletly C; Liu D; Cadiz R; Jacomb I; Catts VS; Weickert CS, 2017, 'SA6. How Reliable are Peripheral Biomarkers of Inflammation in Schizophrenia?', Schizophrenia Bulletin, 43, pp. S114 - S115, http://dx.doi.org/10.1093/schbul/sbx023.005

Klauser P; Baker ST; Cropley VL; Bousman C; Fornito A; Cocchi L; Fullerton JM; Rasser P; Schall U; Henskens F; Michie PT; Loughland C; Catts SV; Mowry B; Weickert TW; Shannon Weickert C; Carr V; Lenroot R; Pantelis C; Zalesky A, 2017, 'White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network Hubs', Schizophrenia Bulletin, 43, pp. 425 - 435, http://dx.doi.org/10.1093/schbul/sbw100

Glass LJ; Sinclair D; Boerrigter D; Naude K; Fung SJ; Brown D; Catts VS; Tooney P; O'Donnell M; Lenroot R; Galletly C; Liu D; Weickert TW; Shannon Weickert C, 2017, 'Brain antibodies in the cortex and blood of people with schizophrenia and controls', Translational Psychiatry, 7, pp. e1192 - e1192, http://dx.doi.org/10.1038/tp.2017.134

Di Biase MA; Zalesky A; O'keefe G; Laskaris L; Baune BT; Weickert CS; Olver J; McGorry PD; Amminger GP; Nelson B; Scott AM; Hickie I; Banati R; Turkheimer F; Yaqub M; Everall IP; Pantelis C; Cropley V, 2017, 'PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia', Translational Psychiatry, 7, pp. e1225 - e1225, http://dx.doi.org/10.1038/tp.2017.193

Purves-Tyson TD; Owens SJ; Rothmond DA; Halliday GM; Double KL; Stevens J; McCrossin T; Shannon Weickert C, 2017, 'Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain', Translational Psychiatry, 7, pp. e1003 - e1003, http://dx.doi.org/10.1038/tp.2016.257

Shannon Weickert C; Cai H; Glass L; Webster M; Boerrigter D; Sinclair D; Catts V, 2017, '767. Evidence for Blood-Brain Barrier Disruption and Antibody Presence in Brains of People with Schizophrenia', Biological Psychiatry, 81, pp. S311 - S312, http://dx.doi.org/10.1016/j.biopsych.2017.02.834

Zhang Y; Catts VS; Sheedy D; McCrossin T; Kril JJ; Shannon Weickert C, 2016, 'Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation', Translational Psychiatry, 6, pp. e982 - e982, http://dx.doi.org/10.1038/tp.2016.238

Weinberg D; Lenroot R; Jacomb I; Allen K; Bruggemann J; Wells R; Balzan R; Liu D; Galletly C; Catts SV; Weickert CS; Weickert TW, 2016, 'Cognitive subtypes of schizophrenia characterized by differential brain volumetric reductions and cognitive decline', JAMA Psychiatry, 73, pp. 1251 - 1259, http://dx.doi.org/10.1001/jamapsychiatry.2016.2925

Kindler J; Weickert CS; Schofield PR; Lenroot R; Weickert TW, 2016, 'Raloxifene increases prefrontal activity during emotional inhibition in schizophrenia based on estrogen receptor genotype', European Neuropsychopharmacology, 26, pp. 1930 - 1940, http://dx.doi.org/10.1016/j.euroneuro.2016.10.009

Corley SM; Tsai SY; Wilkins MR; Weickert CS, 2016, 'Transcriptomic analysis shows decreased cortical expression of nr4a1, nr4a2 and rxrb in schizophrenia and provides evidence for nuclear receptor dysregulation', PLoS ONE, 11, pp. e0166944, http://dx.doi.org/10.1371/journal.pone.0166944

Weissleder C; Fung SJ; Wong MW; Barry G; Double KL; Halliday GM; Webster MJ; Weickert CS, 2016, 'Decline in proliferation and immature neuron markers in the human subependymal zone during aging: Relationship to EGF- and FGF-related transcripts', Frontiers in Aging Neuroscience, 8, pp. 274, http://dx.doi.org/10.3389/fnagi.2016.00274

Back to profile page